| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |